Mike Nowosad Retires From CEO 4-H Canada Position

Dec 14, 2012

CEO of 4-H Canada Retires, New CEO Announcement Expected Early 2013

Mike Nowosad chief executive officer for 4-H Canada retired last month and the 4-H national organization is now seeking new leadership.

Nowosad is known for his many contributions to the 4-H organization. During his 22 years with the organization he was responsible for pushing for a commission to measure the pulse of the organization, which assessed the impact and value of the program across Canada - that report was called “Measures of Success”. He was also instrumental in implementing a national 4-H development network.

Most importantly, Nowosad will be remembered for helping to define what the 4-H organization will stand for as it will mark its 100th anniversary in 2013. The anniversary kickoff will begin with a gala in Winnipeg next spring and will include other special events throughout the year, such as the youth ag summit planed for August.

The new CEO is expected to be named early in 2013.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.